Skip to main content
TTrialFinderData
TrialFinderData is for informational purposes only and does not provide medical advice. Always talk to your doctor.

Clinical Trials in New Hampshire

New Hampshire has 27 clinical trials currently recruiting participants, ranking #42 among all states. The most-studied condition is Ulcerative Colitis with 2 active trials.

27

Total Trials

27

Recruiting

#42

National Rank

15

Conditions

Trials by Phase

14

Not Applicable

2

Phase 1 / Phase 2

1

Phase 2 / Phase 3

3

Phase 1

3

Phase 2

4

Phase 3

Top Conditions in New Hampshire

Top Sponsors in New Hampshire

Cities With Most Trials in New Hampshire

#CityTrials
1Lebanon24
2Manchester3
3Nashua1
4Salem1

Important: This information is for research purposes only. Always talk to your doctor about whether a clinical trial is right for you.

Frequently Asked Questions

New Hampshire currently has 27 clinical trials actively recruiting participants, making it #42 nationally by total trial count.

The most-studied conditions in New Hampshire are Ulcerative Colitis (2 trials), NSCLC (2 trials), Chronic Lymphocytic Leukemia (1 trials).

Browse the conditions listed on this page to find trials recruiting in New Hampshire. Each condition page shows trial details, eligibility criteria in plain English, and contact information. Always talk to your doctor about whether a trial is right for you.

Trial counts reflect currently recruiting studies listed on ClinicalTrials.gov with locations in this state.

The this entity category groups every U.S. clinical trials and research registries entity sharing this attribute. The list above is the data; the paragraphs below explain what the grouping means against the broader the NIH ClinicalTrials.gov registry distribution and how to read the relative rankings within the category.

For readers using this category as a starting point, the per-entity detail pages linked from the table above carry the underlying the NIH ClinicalTrials.gov registry data in full. The category-level view is the filter; the per-entity pages are the actual answer.

Source: ClinicalTrials.gov, 2026.